Literature DB >> 25574055

Correlation between ganglion cell layer thinning and poor visual function after resolution of diabetic macular edema.

Sophie Bonnin1, Ramin Tadayoni1, Ali Erginay1, Pascale Massin1, Bénédicte Dupas1.   

Abstract

PURPOSE: To assess the thickness of the ganglion cell-inner plexiform layer (GCIPL) in eyes with resolved diabetic macular edema (DME), using spectral-domain optical coherence tomography (SD-OCT), and its relationship with the visual function.
METHODS: This retrospective observational case-control cohort study included eyes of diabetic patients with resolved DME (r-DME eyes), that is, normal central macular thickness (CMT) after treatment of DME, and eyes of aged-matched diabetic patients without maculopathy (no-DME eyes). The GCIPL thickness was measured on a macular cube SD-OCT scan using a specific automatic segmentation algorithm. Linear regression analyses were performed to determine the association between the GCIPL thickness and the visual acuity (VA) measured at the time of the OCT measurement.
RESULTS: Average GCIPL thickness was reduced in r-DME eyes compared with no-DME eyes (74 ± 14 μm versus 83.2 ± 6 μm, P = 0.0189), whereas no significant difference in mean CMT was observed (260.0 ± 34 μm versus 265.7 ± 22 μm, P = 0.847). Visual acuity significantly correlated with the average GCIPL thickness (r = 0.8, P < 0.0001) and minimum GCIPL thickness (r = 0.84, P < 0.0001) in r-DME eyes.
CONCLUSIONS: Despite favorable anatomic response and restoration of a CMT in the range of normal values after resolution of DME, the GCIPL thickness in r-DME eyes was lower than that in no-DME eyes and correlated with the VA. These results suggest that inner retinal alterations occurring in patients with DME and diabetic retinopathy may lead to visual deficiency persisting after treatment. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  diabetic macular edema; ganglion cell layer; optical coherence tomography

Mesh:

Year:  2015        PMID: 25574055     DOI: 10.1167/iovs.14-15503

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Ratiometric analysis of optical coherence tomography-measured in vivo retinal layer thicknesses for the detection of early diabetic retinopathy.

Authors:  Basanta Bhaduri; Ryan L Shelton; Ryan M Nolan; Lucas Hendren; Alexandra Almasov; Leanne T Labriola; Stephen A Boppart
Journal:  J Biophotonics       Date:  2017-06-21       Impact factor: 3.207

2.  Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia.

Authors:  Wendy A Dailey; Kimberly A Drenser; Sui Chien Wong; Mei Cheng; Joseph Vercellone; Kevin K Roumayah; Erin V Feeney; Mrinalini Deshpande; Alvaro E Guzman; Michael Trese; Kenneth P Mitton
Journal:  Exp Eye Res       Date:  2017-08-18       Impact factor: 3.467

3.  Contrast sensitivity is associated with outer-retina thickness in early-stage diabetic retinopathy.

Authors:  J Jason McAnany; Jason C Park; Karen Liu; Michelle Liu; Yi-Fan Chen; Felix Y Chau; Jennifer I Lim
Journal:  Acta Ophthalmol       Date:  2019-09-13       Impact factor: 3.761

Review 4.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

5.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Authors:  Elliott H Sohn; Hille W van Dijk; Chunhua Jiao; Pauline H B Kok; Woojin Jeong; Nazli Demirkaya; Allison Garmager; Ferdinand Wit; Murat Kucukevcilioglu; Mirjam E J van Velthoven; J Hans DeVries; Robert F Mullins; Markus H Kuehn; Reinier Otto Schlingemann; Milan Sonka; Frank D Verbraak; Michael David Abràmoff
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

6.  The correlation between visual acuity outcomes and optical coherence tomography parameters following surgery for diabetic epiretinal membrane and taut posterior hyaloid.

Authors:  Hülya Güngel; Zeynep Kayaarası Öztürker; Sibel Zırtıloğlu; Kadir Eltutar
Journal:  Clin Ophthalmol       Date:  2015-08-18

7.  Exploring the angiographic-biologic phenotype in the IMAGINE study: quantitative UWFA and cytokine expression.

Authors:  Joseph R Abraham; Charles C Wykoff; Sruthi Arepalli; Leina Lunasco; Hannah J Yu; Alison Martin; Christopher Mugnaini; Ming Hu; Jamie Reese; Sunil K Srivastava; David M Brown; Justis P Ehlers
Journal:  Br J Ophthalmol       Date:  2021-06-07       Impact factor: 5.908

Review 8.  Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.

Authors:  Cristina Hernández; Massimo Dal Monte; Rafael Simó; Giovanni Casini
Journal:  J Diabetes Res       Date:  2016-03-31       Impact factor: 4.011

9.  Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study.

Authors:  Pascale Massin; Ali Erginay; Bénédicte Dupas; Aude Couturier; Ramin Tadayoni
Journal:  Clin Ophthalmol       Date:  2016-07-08

10.  The measurement repeatability using different partition methods of intraretinal tomographic thickness maps in healthy human subjects.

Authors:  Jia Tan; Ye Yang; Hong Jiang; Che Liu; Zhihong Deng; Byron L Lam; Liang Hu; Jonathan Oakley; Jianhua Wang
Journal:  Clin Ophthalmol       Date:  2016-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.